HMB (Beta-Hydroxy-Beta-Methylbutyrate): What the Evidence Actually Says About This Muscle-Preserving Leucine Metabolite
HMB (Beta-Hydroxy-Beta-Methylbutyrate): What the Evidence Actually Says About This Muscle-Preserving Leucine Metabolite
When Texas A&M nutrition scientist Nicolaas Deutz tracked 652 malnourished, hospitalized older adults for 90 days after discharge, the group drinking a supplement containing a little-known leucine metabolite called HMB was roughly half as likely to be dead — 4.8% mortality versus 9.7% on placebo. The result put beta-hydroxy-beta-methylbutyrate on the map as far more than a bodybuilder's recovery aid. Discovered decades earlier by Iowa State's Steven Nissen, HMB is now the subject of a 2025 position stand from the International Society of Sports Nutrition and a growing stack of meta-analyses asking a single, urgent question: can this muscle metabolite help you hold onto muscle — the organ of longevity — as you age? Here is what the evidence actually shows.
Evidence Tier: 🥈 Silver. Multiple meta-analyses of randomized controlled trials support modest gains in muscle mass and strength in older adults — but the headline mortality finding rests on a single trial in a specific hospitalized population, and HMB adds little on top of exercise in the very old.
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: A 2025 umbrella review of 11 meta-analyses found HMB significantly increased muscle mass, strength, and fat-free mass — with the biggest effects in older adults.
- Mortality signal: In the 652-person NOURISH trial, malnourished hospitalized older adults taking HMB had 90-day mortality of 4.8% vs 9.7% on placebo (relative risk 0.49).
- Preserves muscle during inactivity: HMB consistently helps limit muscle loss during bed rest, illness, and disuse — exactly when older adults lose muscle fastest.
- Safety: Rare, mild side effects (mostly stomach upset), no effect on cholesterol, blood sugar, or insulin, and safety data covering up to a year of daily use.
❌ Cons (What the Evidence Doesn't Support or Warns About)
- Biggest limitation: No lifespan data, and the striking mortality result comes from one trial in hospitalized, malnourished patients — it may not apply to healthy adults.
- Modest effect sizes: The gains are real but small — an umbrella review found a muscle-mass effect size of just 0.21, and no improvement in walking speed.
- Little benefit for the young and fit: A 2020 meta-analysis found HMB does not improve body composition or strength in healthy young adults who train.
- Who should avoid: Anyone with kidney or liver disease, or who is pregnant or breastfeeding, should check with a doctor first; the calcium form adds about 300 mg of calcium per daily dose.
What Is HMB?
Beta-hydroxy-beta-methylbutyrate (HMB) is a natural metabolite of leucine — leucine being the essential amino acid most responsible for triggering muscle growth. When you eat protein, your body converts roughly 5% of its leucine into HMB. The problem is scale: to get the 3 grams of HMB used in research, you would need to eat an impossible amount of leucine. That is why HMB is taken as a supplement rather than obtained from food.
HMB was discovered in the 1980s–1990s by Iowa State University's Steven Nissen, who noticed that when leucine was metabolized in muscle, a small byproduct — HMB — appeared to do the heavy lifting for muscle protection. It was originally sold as a sports-nutrition supplement for athletes. Over the past decade, though, the research focus has shifted to where HMB arguably matters more: preventing age-related muscle loss, the gradual wasting of muscle (sarcopenia) that begins after 40 and accelerates after 70.
HMB comes in two main forms: calcium HMB (HMB-Ca), the most-studied and cheapest, and free-acid HMB (HMB-FA), which reaches the bloodstream faster. Both deliver the same active molecule.
How It Works
HMB is unusual because it attacks muscle loss from both ends at once — and the 2025 ISSN position stand pins down exactly how:
- Boosts muscle protein synthesis: HMB activates the mTORC1 pathway — the master switch your cells use to build protein. Importantly, it does this through a route that is independent of the normal leucine-sensing machinery (the Sestrin2-GATOR2 complex). That matters because aged muscle becomes "anabolic-resistant" — it stops responding well to normal protein signals. HMB takes a back door around that resistance.
- Suppresses muscle protein breakdown: At the same time, HMB dials down the ubiquitin-proteasome system, the cell's protein-shredding machinery that runs too hot during aging, illness, and inactivity.
- Anti-inflammatory and mitochondrial support: A 2025 study in Biogerontology found HMB also regulates autophagy (cellular cleanup) and preserves mitochondrial function — protecting the muscle stem cells (satellite cells) that repair and rebuild muscle as you age.
The net effect is a slower leak of muscle protein — which is precisely what you want when the natural drift of aging is to break muscle down faster than you rebuild it.
The Longevity Connection
Muscle is increasingly called the organ of longevity. Low muscle mass and strength in older age predict falls, disability, loss of independence, and earlier death better than almost any other single measure. So a supplement that helps preserve muscle is, by definition, a longevity intervention. Here is how the evidence breaks down by outcome:
Muscle Mass & Sarcopenia (🥈 Silver — the strongest evidence)
The most consistent finding across the literature is that HMB helps older adults hold onto muscle. A 2015 meta-analysis of 7 randomized trials (147 people on HMB, 140 controls) found significantly greater muscle-mass gain (standardized mean difference 0.352 kg, p = 0.004). A 2025 umbrella review pooling 11 meta-analyses confirmed small but significant gains in muscle mass (effect size 0.21) and fat-free mass (0.22). And a 2025 meta-analysis focused specifically on people with diagnosed sarcopenia found HMB improved both skeletal muscle index (SMD 0.32) and handgrip strength (SMD 0.65).
Mortality (🥈 Silver — one striking but isolated trial)
The single most headline-grabbing data point is the NOURISH trial (Deutz et al., 2016). In 652 malnourished older adults hospitalized for heart failure, heart attack, pneumonia, or COPD, a high-protein drink containing HMB cut 90-day mortality from 9.7% to 4.8% — a relative risk of 0.49 (p = 0.018). The number needed to treat to prevent one death was 20. It is worth emphasizing this is one trial, in a sick, hospitalized population — an impressive signal, but not proof that HMB extends lifespan in healthy people.
Strength & Physical Function (🥈 Silver)
A 2022 meta-analysis of 9 trials and 896 elderly people found HMB significantly improved muscle strength (SMD 0.41). A 2023 randomized, double-blind trial in older adults with sarcopenia found that adding HMB to resistance training boosted handgrip strength by an extra 4.61 kg and gait speed by 0.11 m/s versus placebo-plus-training. The honest caveat: most meta-analyses find the physical performance benefits (like walking speed) weaker or nonsignificant, which is why the overall grade stays Silver.
Bed Rest, Illness & Disuse (🥈 Silver — where HMB shines)
Muscle is lost fastest when you stop using it — during hospitalization, injury, or prolonged sitting. The ISSN position stand specifically highlights HMB as useful for "countering muscle disuse atrophy during periods of inactivity due to illness or injury." A 2025 Biogerontology study confirmed the mechanism in animals, showing HMB preserves muscle mass and function during inactivity and protein deprivation.
Cancer & Cachexia (🥈 Silver, emerging)
A 2022 systematic review found that in patients with active cancer, HMB (3 g/day in 80% of studies) showed benefit for muscle mass and function in the higher-quality trials, with a favorable signal on survival and no serious side effects. This is a population where preserving muscle can directly extend both quality and quantity of life.
What It Does NOT Do (⚠️ important negative)
In healthy young adults who resistance-train, HMB is a dud. A 2020 meta-analysis of 11 trials (302 participants aged 18–45) found no significant effect on fat-free mass, fat mass, or strength. And in a 2024 trial of institutionalized adults averaging 83 years old, HMB added no benefit on top of a structured exercise program. The pattern is clear: HMB helps when muscle is under threat — aging, illness, inactivity — not when a young, healthy body is already building muscle fine on its own.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| NOURISH trial (Deutz et al., Clin Nutr, 2016) | Multicenter RCT, 652 malnourished hospitalized adults ≥65 | 90-day mortality 4.8% vs 9.7% (RR 0.49, p=0.018); NNT to prevent one death = 20. |
| ISSN Position Stand (J Int Soc Sports Nutr, 2025) | Authoritative position statement, 12 points | Dose 38 mg/kg/day (~3 g); safe up to 1 year; dual mechanism (synthesis up, breakdown down); useful in aging and disuse. |
| Umbrella review (J Cachexia Sarcopenia Muscle, 2025) | 11 meta-analyses, 41 datasets, ages 23–79 | Muscle mass ES 0.21 (p=0.004), strength ES 0.27 (p<0.001), fat-free mass ES 0.22 (p<0.001). |
| Sarcopenia meta-analysis (Maturitas, 2025) | 5 RCTs, 154–359 people per outcome | Skeletal muscle index SMD 0.32 (p=0.048); handgrip SMD 0.65 (p=0.034); no gait-speed benefit. |
| Wu et al. meta-analysis (Arch Gerontol Geriatr, 2015) | 7 RCTs, 147 HMB vs 140 control (≥65) | Muscle-mass gain SMD 0.352 kg (p=0.004); no fat-mass change. |
| Sarcopenia RCT (J Nutr Health Aging, 2023) | Double-blind, placebo-controlled, 34 adults ≥60 with sarcopenia, 12 weeks | HMB + resistance training added +4.61 kg handgrip, +0.11 m/s gait speed, and reduced inflammation vs placebo + training. |
| Elderly strength meta-analysis (Front Nutr, 2022) | 9 RCTs, 896 elderly | Muscle strength SMD 0.41 (95% CI 0.28–0.54). |
| 12-week multicentre RCT (Nutr J, 2025) | 110 older adults ≥65 with sarcopenia | HMB + protein + vitamin D + exercise added +0.60 kg appendicular lean mass and +2.22 kg handgrip vs control. |
| Cancer systematic review (J Cachexia Sarcopenia Muscle, 2022) | 15 studies, 6 RCTs, various cancers | Benefit for muscle mass/function in higher-quality trials; favorable survival signal; no serious adverse events. |
| Young-adult meta-analysis (Nutrients, 2020) | 11 RCTs, 302 adults 18–45 | No significant effect on fat-free mass, fat mass, or strength — HMB does not help young trained adults. |
Dosing and Safety
What the Trials Used
| Goal | Dose | Notes |
|---|---|---|
| Standard (ISSN, most trials) | 3 g/day (≈38 mg/kg body weight) | The dose used in the large majority of human studies. |
| Split dosing for better absorption | 1.5 g twice daily, or 1 g three times daily | Dividing the dose keeps blood levels steadier than one large dose. |
| Free-acid vs calcium form | Same 3 g/day | HMB-FA peaks in blood ~2× faster; HMB-Ca is cheaper and most studied. Both work. |
Form Selection
- HMB-Ca (calcium HMB): The most-studied form; note that 3 g of HMB-Ca delivers roughly 300–400 mg of elemental calcium, which matters if you track calcium intake.
- HMB-FA (free acid): Absorbs faster and reaches a higher peak, which some athletes prefer for timing around workouts — but for daily muscle preservation the difference is minor.
- Pair with protein and resistance exercise: The best results in trials come from HMB combined with adequate protein and, ideally, some resistance training. HMB is an amplifier, not a replacement for lifting.
Side Effects & Safety
| Side Effect | Frequency | Notes |
|---|---|---|
| Mild stomach upset | Occasional | Usually resolves when taken with food. |
| Changes to cholesterol, blood sugar, or insulin | None observed | A 2024 GRADE-assessed meta-analysis found no effect on lipids; ISSN notes no negative effects on glucose tolerance. |
Safety note: HMB has an unusually clean record for a supplement. The ISSN position stand states that chronic HMB use is safe for at least one year, and long-term animal studies show no toxicity. Because HMB is a leucine metabolite rather than a hormone, it does not carry the risks of anabolic steroids or testosterone precursors. The main caution is for people with kidney or liver disease, who should clear it with a doctor — the amino-acid load, while small, is still processed through those organs.
❓ Common Questions About HMB
What is HMB and how does it work?
HMB (beta-hydroxy-beta-methylbutyrate) is a natural breakdown product of leucine, one of the amino acids in protein. It helps muscle in two ways: it turns on muscle building and turns down muscle breakdown. Your body only makes a tiny amount of it from food, so a supplement delivers a far bigger dose.
What does the evidence actually show?
In older adults, meta-analyses of randomized trials show HMB modestly increases muscle mass and strength, and one 652-person hospital trial found it cut deaths over 90 days by roughly half. But it does not seem to help young, fit people, and it adds little on top of exercise in the very old. The evidence is strongest for preserving muscle in older or frail adults.
What's the right dose?
The standard dose is 3 grams a day, usually split into two or three smaller doses of about 1 to 1.5 grams each. The free-acid form (HMB-FA) absorbs faster, while the calcium form (HMB-Ca) is cheaper and the most studied. It works best alongside protein and resistance exercise.
What are the risks and side effects?
HMB is one of the safer supplements studied. Side effects are rare and mild, mostly occasional stomach upset. It does not appear to change cholesterol, blood sugar, or insulin, and safety data cover use up to a year.
Who should avoid it?
Most people tolerate HMB well, but anyone with kidney disease, liver disease, or who is pregnant or breastfeeding should check with a doctor first. It is probably not worth the cost for healthy young people who lift weights, since studies show little benefit there.
The Bottom Line
HMB is not a miracle molecule, and it is not rapamycin. But for a very specific — and very common — aging problem, it has an unusually consistent evidence base: helping older and frail adults hold onto muscle. Across multiple meta-analyses, HMB modestly but reliably increases muscle mass and strength in this population, and the NOURISH trial's 50% reduction in 90-day mortality in malnourished hospitalized patients is a genuinely striking (if single) data point.
The honest picture has clear edges. HMB does little for healthy young people who already lift weights. It adds little on top of a robust exercise program in the very old. And its effect sizes are modest — it slows the leak of muscle, rather than reversing it. That is why this page grades it 🥈 Silver overall, with the muscle-preservation evidence being the strongest pillar.
Our verdict: If you are over 50, especially if you are losing strength, recovering from illness or surgery, on a hospital or bed-rest stint, or simply cannot train as hard as you used to, HMB at 3 g/day is a low-risk, modest-cost, evidence-backed addition to protein and (where possible) resistance exercise. If you are a healthy 30-year-old who lifts regularly, save your money — the evidence says HMB has little to offer you. As always, the exercise itself remains the single most powerful muscle-preservation tool we have; HMB is a supporting player, not the star.
Medical Disclaimer: This page is for educational purposes only and is not medical advice. Supplements can interact with medications and are not right for everyone. Always consult a qualified healthcare provider before starting any supplement, especially if you are pregnant, breastfeeding, taking medication, or managing a health condition. See our full disclaimer.
Sources
- Deutz NE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr. 2016. PMID 26797412
- International Society of Sports Nutrition. Position stand: β-hydroxy-β-methylbutyrate (HMB). J Int Soc Sports Nutr. 2025. PMID 39699070
- Ergogenic Benefits of β-Hydroxy-β-Methyl Butyrate (HMB) Supplementation on Body Composition and Muscle Strength: An Umbrella Review of Meta-Analyses. J Cachexia Sarcopenia Muscle. 2025. PMID 39797501
- The effects of β-hydroxy-β-methylbutyrate supplementation in patients with sarcopenia: A systematic review and meta-analysis. Maturitas. 2025. PMID 39999663
- The Role of HMB Supplementation in Enhancing the Effects of Resistance Training in Older Adults. Nutrients. 2025. PMID 41305674
- β-hydroxy-β-methylbutyrate supplementation mitigates muscle atrophy induced by inactivity and protein deprivation. Biogerontology. 2025. PMID 40531264
- Effects of combined nutritional supplementation and exercise on proxy measures of muscle mass, strength, and function in older adults with sarcopenia: a 12-week multicentre RCT. Nutr J. 2025. PMID 41350709
- Effects of multicomponent training and HMB supplementation on disability, cognitive and physical function in institutionalized older adults aged over 70 years. J Nutr Health Aging. 2024. PMID 38489992
- Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study. J Nutr Health Aging. 2023. PMID 37248756
- Effect of β-hydroxy-β-methylbutyrate (HMB) on the Muscle Strength in the Elderly Population: A Meta-Analysis. Front Nutr. 2022. PMID 35911112
- Effects of β-hydroxy β-methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review. J Cachexia Sarcopenia Muscle. 2022. PMID 35301826
- Effects of β-hydroxy-β-methylbutyrate (HMB) supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis. Front Nutr. 2024. PMID 39385778
- Supplementation with the Leucine Metabolite β-hydroxy-β-methylbutyrate (HMB) does not Improve Resistance Exercise-Induced Changes in Body Composition or Strength in Young Subjects. Nutrients. 2020. PMID 32456217
- Wu H, et al. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2015. PMID 26169182
- Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review. Nutr Rev. 2021. PMID 32483625